Askal Ayalew Ali (Askal Ali, Askal A Ali)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Diabetic Nephropathy

Systematic Review

Positive Breast Cancer

Sentinel Lymph Node

Top Venues

PharmacoEconomics

Expert review of pharmacoeconomics & outcomes research

Clinical drug investigation

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Askal Ayalew Ali, Amit Kulkarni, Sandipan Bhattacharjee, Vakaramoko Diaby
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. PharmacoEconomics (2024)
Askal Ayalew Ali, Amit Kulkarni, Sandipan Bhattacharjee, Vakaramoko Diaby
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. PharmacoEconomics 42 (Suppl 2) (2024)
Askal Ayalew Ali, Amit Kulkarni, Sandipan Bhattacharjee, Vakaramoko Diaby
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. PharmacoEconomics 42 (Suppl 2) (2024)
Askal Ayalew Ali, Amit Kulkarni, Sandipan Bhattacharjee, Vakaramoko Diaby
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. PharmacoEconomics 42 (Suppl 2) (2024)
Georges Adunlin, Jordan Skiera, Chandler S Cupp, Askal Ayalew Ali, Serge Amani Yao Afeli
The State of Pharmacoeconomics Education in the Doctor of Pharmacy Curriculum amid the Changing Face of Pharmacy Practice. Healthcare (Basel, Switzerland) 11 (22) (2023)
Tadesse M Abegaz, Vakaramoko Diaby, Fatimah Sherbeny, Askal Ayalew Ali
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA. Clinical drug investigation 42 (6) (2022)
Askal Ayalew Ali, Rima H Tawk, Hong Xiao, Anastasia Semykina, Alberto J Montero, Richard K Moussa, Olayiwola Popoola, Vakaramoko Diaby
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer. Expert review of pharmacoeconomics & outcomes research 22 (5) (2022)
Vakaramoko Diaby, Reem D Almutairi, Aram Babcock, Richard K Moussa, Askal Ayalew Ali
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)
Askal Ayalew Ali, Rima Tawk, Hong Xiao, Ellen Campbell, Anastasia Semykina, Alberto J Montero, Muluberhan Mogos, Vakaramoko Diaby
Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data. Cancer medicine 8 (1) (2018)